Baird Medical Investment Holdings (BDMD) Liabilities and Shareholders Equity (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $73.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 4.08% year-over-year to $73.8 million in Q2 2026; TTM through Jun 2026 was $298.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $69.7 million, down 10.6% from the prior year.
• Liabilities and Shareholders Equity was $73.8 million for Q2 2026 at Baird Medical Investment Holdings, up from $69.7 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $78.0 million in Q4 2024 and troughed at $56.7 million in Q4 2023.
• A 4-year average of $71.0 million and a median of $73.8 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity soared 37.48% in 2024 and slipped 10.6% in 2025, its largest moves.
• Over 4 years, Liabilities and Shareholders Equity stood at $56.7 million in 2023, then jumped by 37.48% to $78.0 million in 2024, then dropped by 10.6% to $69.7 million in 2025, then advanced by 5.95% to $73.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $73.8 million (Q2 2026), $69.7 million (Q4 2025), and $77.0 million (Q2 2025), per Business Quant data.